The APL Paradigm and the “Co-Clinical Trial” Project
- 1 July 2011
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Discovery
- Vol. 1 (2), 108-116
- https://doi.org/10.1158/2159-8290.cd-11-0061
Abstract
Tremendous advances in technologies have allowed the attainment of powerful insights into the molecular and genetic determinants that drive human cancers. However, this acquired knowledge has been translated into effective therapeutics very slowly, in part due to difficulty in predicting which drug or drug combination is likely to be effective in the complex mutational background of human cancers. To address this difficulty we have proposed and initiated the “co-clinical trial” project, in which we exploit mouse models that faithfully replicate the variety of mutational events observed in human cancers, to conduct preclinical trials that parallel ongoing human phase I/II clinical trials. Here, we focus on concepts relevant to the application of this novel paradigm and the essential components required for its implementation to ultimately achieve the rational and rapid development of new therapeutic treatments. Cancer Discovery; 1(2); 108–16. ©2011 AACR.Keywords
This publication has 16 references indexed in Scilit:
- Eradication of acute promyelocytic leukemia-initiating cells by PML/RARA-targetingInternational Journal of Hematology, 2010
- Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradationNature Medicine, 2008
- Leukemia with distinct phenotypes in transgenic mice expressing PML/RARα, PLZF/RARα or NPM/RARαOncogene, 2005
- Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemiaJCI Insight, 2001
- The theory of APLOncogene, 2001
- Transcription therapy for cancerOncogene, 2001
- Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APLNature Genetics, 1998
- Arsenic Trioxide as an Inducer of Apoptosis and Loss of PML/RARα Protein in Acute Promyelocytic Leukemia CellsJNCI Journal of the National Cancer Institute, 1998
- Acute leukemia with promyelocytic features in PML/RARα transgenic miceProceedings of the National Academy of Sciences of the United States of America, 1997
- Chromosomal Patterns in Myelocytic LeukemiaNew England Journal of Medicine, 1973